BioSpace News Archive

Pharm Country

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

22nd Century Group, Inc. (Nasdaq: XXII), announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Company’s VLN® King and VLN® Menthol King reduced nicotine content cigarettes as modified risk tobacco products (MRTPs).

December 23, 2021
·
9 min read
BioMidwest

ViewRay to Participate in the 40th Annual J.P. Morgan Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 40th Annual J.P. Morgan Healthcare Conference.

December 23, 2021
·
1 min read
Business

Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer

Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, announced the appointment of Giuliano La Fratta as Senior Vice President, Chief Financial Officer.

December 23, 2021
·
5 min read
Deals

Larkspur Health Acquisition Corp. Announces Closing of $75 Million Initial Public Offering

Larkspur Health Acquisition Corp., a newly organized blank-check special purpose acquisition company formed as a Delaware corporation, today announced the closing of its initial public offering of 7,500,000 units at an offering price of $10.00 per unit.

December 23, 2021
·
3 min read
Business

INVESTIGATIONAL ALZHEIMER’S DISEASE THERAPY LECANEMAB GRANTED FDA FAST TRACK DESIGNATION

Eisai Co., Ltd. and Biogen Inc. announced today that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of early Alzheimer was granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

December 23, 2021
·
11 min read
Deals

BiondVax Announces Proposed Underwritten Public Offering of American Depositary Shares

BiondVax Pharmaceuticals Ltd. today announced that it intends to offer its American Depositary Shares (“ADSs”) in an underwritten public offering.

December 23, 2021
·
5 min read
The Medical Products Agency in Sweden will be reference member state for Moberg Pharma’s European registration application

The Medical Products Agency in Sweden has agreed to be reference member state for Moberg Pharma AB’s registration application for MOB-015.

December 23, 2021
·
2 min read
Policy

Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*

On June 14, 2021, Royal Philips’ subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain sleep and respiratory care products to address potential health risks related to the polyester-based polyurethane sound abatement foam in these devices.

December 23, 2021
·
4 min read
Business

Experienced Pharmaceutical Industry Executive Dr. Elisabeth Svanberg Appointed as Chairman of Pharnext Board of Directors

Pharnext SA announces the appointment of Dr. Elisabeth Svanberg MD, PhD to succeed Michel de Rosen as Chairman of the Board of Directors effective January 1st, 2022.

December 23, 2021
·
6 min read
Deals

IBEX Announces Stock Option Grant to Directors and Employees

IBEX Technologies Inc. (TSX Venture: IBT), today announced that on December 22, 2021 the Company’s Board of Directors granted stock options representing a total of 450,000 common shares to its directors and an officer of the Company.

December 23, 2021
·
2 min read